Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 22, 2024

SELL
$26.13 - $33.94 $26,130 - $33,940
-1,000 Reduced 10.29%
8,715 $250,000
Q3 2023

Oct 27, 2023

SELL
$32.09 - $37.51 $23,104 - $27,007
-720 Reduced 6.9%
9,715 $322,000
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $214,191 - $247,814
-5,930 Reduced 36.24%
10,435 $382,000
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $729,699 - $949,962
-18,525 Reduced 53.1%
16,365 $667,000
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $4,175 - $5,450
-100 Reduced 0.29%
34,890 $1.79 Million
Q3 2022

Nov 09, 2022

SELL
$43.76 - $53.42 $15,316 - $18,697
-350 Reduced 0.99%
34,990 $1.53 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $62,117 - $73,651
-1,335 Reduced 3.64%
35,340 $1.85 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $105,316 - $130,500
-2,302 Reduced 5.91%
36,675 $1.9 Million
Q4 2021

May 09, 2022

BUY
$41.32 - $61.25 $1.61 Million - $2.39 Million
38,977 New
38,977 $2.3 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Insight Inv LLC Portfolio

Follow Insight Inv LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Insight Inv LLC, based on Form 13F filings with the SEC.

News

Stay updated on Insight Inv LLC with notifications on news.